Category Archive: multidrug resistance

Feb 14

Center for the Translational Sciences Indiana Awards us Seed Grant for an Innovative Antibiotic Free Nanotherapeutics to Combat Multi-drug Resistant Bacterial Infections

Categories:

AD&T Notre Dame, antibiotics, Antimicrobial, Berthiaume Institute for Precision Health, Grants funding, multidrug resistance

Biomedical research is at risk of losing the antibiotics vs. pathogens arms race. Pneumonia, tuberculosis, gonorrhea, and salmonellosis are becoming harder and sometimes impossible to treat due to the fast emergence and global spread of new antibiotic resistance. Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries …

Continue reading »

Tags: NDNano

Recent Posts

Recent Comments

Archives

Categories

NIH Funding Opportunities

Notice of Special Interest (NOSI): Understanding and Addressing Weight Stigma, Bias, and Discrimination to Promote Health Equity January 14, 2025
Notice NOT-HL-24-032 from the NIH Guide for Grants and Contracts
Notice of Change: Only BESH CT Applications Accepted in PAR-25-050, PAR-24-098, PAR-25-055, PAR-24-096 January 14, 2025
Notice NOT-NS-25-009 from the NIH Guide for Grants and Contracts
NCI Pathway to Independence Award (K99/R00 Clinical Trial Required) January 14, 2025
Funding Opportunity PAR-25-313 from the NIH Guide for Grants and Contracts. The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide […]
Notice of Intent to Publish a Funding Opportunity Announcement for U.S. and Low- and Middle-Income Countries (LMICs) HIV Associated Malignancy Research Centers (U54 Clinical Trial Optional) January 14, 2025
Notice NOT-CA-25-022 from the NIH Guide for Grants and Contracts
An Introduction to the NIH Fellowship Program for Prospective Candidates - Registration Open for February 11, 2025, Webinar January 14, 2025
Notice NOT-OD-25-064 from the NIH Guide for Grants and Contracts
NEI Notice of Participation in PA-23-317, "Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)" January 13, 2025
Notice NOT-EY-25-005 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Understanding Alzheimer's Disease in the Context of the Aging Brain January 13, 2025
Notice NOT-AG-24-032 from the NIH Guide for Grants and Contracts
Molecular Mechanisms of Combination Adjuvants (MMCA) (R01 Clinical Trial Not Allowed) January 13, 2025
Funding Opportunity RFA-AI-25-006 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research studies of two or more vaccine adjuvants (combination adjuvants) in order to understand the mechanisms by which they work in concert. All adjuvants considered must have previously demonstrated immune modulating activity. […]
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) January 13, 2025
Funding Opportunity PAR-25-342 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support innovative and interdisciplinary research teams focused on clinical, health services, and/or community-based interventions that address health and healthcare disparities related to non-communicable and chronic diseases (NCDs) with the highest burden and mortality […]
Notice of Change to Key Dates Listed in RFA-AG-24-049, "Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed)" January 13, 2025
Notice NOT-AG-24-089 from the NIH Guide for Grants and Contracts